IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis

Journal of Clinical Investigation

Volumn 112, Issue 8, 2003, Pages 1186-1191

  Becher, Burkhard ^a,b,c   Durell, Brigit G ^b   Noelle, Randolph J ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b DARTMOUTH COLLEGE   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 23; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN P40;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; BONE MARROW CELL; BRAIN CELL; CENTRAL NERVOUS SYSTEM; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EFFECTOR CELL; ENCEPHALITIS; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MICROGLIA; MOUSE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PARENCHYMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; BRAIN; CELL POLARITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNIZATION; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; MICE; MICE, INBRED C57BL; MICROGLIA; MYELIN-ASSOCIATED GLYCOPROTEIN; PROTEIN SUBUNITS; T-LYMPHOCYTES; TH1 CELLS;

EID: 0347357773     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200319079     Document Type: Article

References (16)

1. Becher, B., Dutell, B.G., and Noelle, R.J. 2002. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 110:493-497. doi:10.1172/JCI200215751.
2. Gran, B., et al. 2002. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169:7104-7110.
3. Cua, D.J., et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for auroimmune inflammation of the brain. Nature. 421:744-748.
4. Oppmann, B., et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13:715-725.
5. Gately, M.K., et al. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:495-521.
6. Windhagen, A., et al. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1985-1996.
7. Issazadeh, S., Navikas, V., Schaub, M., Sayegh, M., and Khoury, S. 1998. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 161:1104-1112.
8. Aloisi, F., Penna, G., Polazzi, E., Minghetti, L., and Adorini, L. 1999. CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells. J. Immunol. 162:1384-1391.
9. Becher, B., Prat, A., and Antel, J.P. 2000. Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia. 29:293-304.
10. Becher, B., Dodelet, V., Fedorowicz, V., and Antel, J.P. 1996. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J. Clin. Invest. 98:1539-1543.
11. Becher, B., Durell, B.G., Miga, A.V., Hickey, W.F., and Noelle, R.J. 2001. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J. Exp. Med. 193:967-974.
12. Korner, H., et al. 1997. Critical points of tumor necrosis factor action in CNS autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1585-1590.
13. Chu, C.Q., Wittmer, S., and Dalton, D.K. 2000. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192:123-128.
14. Willenborg, D.O., Fordham, S., Bernard, C.C., Cowden, W.B., and Ramshaw, I.A. 1996. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:3223-3227.
15. Krakowski, M., and Owens, T. 1996. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1641-1646.
16. Frei, K., et al. 1997. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185:2177-2182.